COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as CellulitisCase Studies Published on 2021-06-122024-09-04 Journal: Journal of Primary Care & Community Health [Category] 대상포진, [키워드] COVID arm COVID-19 vaccine Delayed hypersensitivity reactions mRNA vaccines post-vaccination reactions Skin and soft tissue infection T-cell mediated treatment of COVID arm vaccine allergy vaccine safety [DOI] 10.1177/21501327211024431 PMC 바로가기 [Article Type] Case Studies
Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine exampleRegular paper Published on 2021-06-112024-09-04 Journal: Vaccine: X [Category] 대상포진, [키워드] hepatitis B vaccine Post-licensure studies Post-marketing requirement Real-world evidence vaccine safety [DOI] 10.1016/j.jvacx.2021.100101 PMC 바로가기 [Article Type] Regular paper
Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous MisinformationImmunology Published on 2021-06-102022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, [키워드] adjuvants aluminum Anxiety cleaning concerning correlation distribution FIVE formaldehyde Genetic genetic vaccines Health immunization inactivation include information medication misinformation parent Patient prejudice raised Research researcher selected Side effect Side effects Support target threat vaccination Vaccine Vaccine hesitancy vaccine safety Vaccines WHO World Health Organization [DOI] 10.3389/fimmu.2021.663280 PMC 바로가기 [Article Type] Immunology
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccinesReview Published on 2021-05-142023-06-16 Journal: Vaccine [Category] MERS, SARS, [키워드] adverse events Background rates COVID-19 incidence rates Surveillance vaccine safety [DOI] 10.1016/j.vaccine.2021.05.016 PMC 바로가기 [Article Type] Review
Review the safety of Covid-19 mRNA vaccines: a reviewReview Published on 2021-05-012022-10-28 Journal: Patient Safety in Surgery [Category] COVID-19, [키워드] acute respiratory syndrome adverse effect Adverse reactions approved Community coronavirus COVID-19 COVID-19 infection death doses Efficacy Emergency use authorization FDA Immunity Moderna mRNA mRNA vaccine mRNA vaccines novel coronavirus disease pandemic Pfizer/BioNTech platform raised reported review SARS-CoV-2 Side effect storage conditions the United State The United States the vaccine Trial vaccination Vaccine Vaccine development vaccine safety widespread [DOI] 10.1186/s13037-021-00291-9 PMC 바로가기 [Article Type] Review
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 VaccinationArticle Published on 2021-04-292022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Activation Adenoviral vector-based vaccine adjuvanticity Adverse affected age Autoimmune average BNT ChAdOx1 vaccines condition corticosteroid therapy country COVID-19 Demyelination disease disease expression disease onset disease phenotype dose evaluated explained Features female FIVE flare Immune-mediated immune-mediated disease immune-mediated diseases immunization Inflammatory mechanism Mild moderate MOST mRNA-1273 mRNA-based vaccine occurred organ Other outcomes over pathogenic Patient receiving Region SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine severity Side effect small fiber the patient the timing therapy TLR-7/8 USA vaccination Vaccine vaccine safety [DOI] 10.3390/vaccines9050435 PMC 바로가기 [Article Type] Article
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies비활성화된 SARS-CoV-2 백신의 면역원성과 안전성: 전임상 연구Article Published on 2021-03-032022-09-10 Journal: Vaccines [Category] 비임상, [키워드] Antibody titers approved AstraZeneca booster booster dose breath candidate vaccine challenge clinical development clinical trial control group country effective Efficacy Emergency use experimental models guinea pigs hamster hamsters immunogenicity immunological profile inactivated increase in Infection Laboratory mice Moderna morbidity mRNA Neutralizing antibody titer neutralizing antibody titers pandemic performed Phase I PIGS post vaccination pre-clinical study Preclinical preclinical studies RATs Safety safety evaluation SARS-CoV-2 SARS-CoV-2 vaccine shedding Sinopharm subjects tested the vaccine tolerable Vaccine vaccine safety virus [DOI] 10.3390/vaccines9030214 PMC 바로가기 [Article Type] Article
The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendationsArticle Published on 2021-01-302023-07-01 Journal: American journal of obstetrics and gynecology [Category] SARS, [키워드] coronavirus Coronavirus disease 2019 COVID-19 vaccine Influenza A H1N1 lactation maternal immunity Middle East respiratory syndrome mRNA vaccine Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 vaccine safety Zika [DOI] 10.1016/j.ajog.2021.01.022 PMC 바로가기
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next GenerationMeeting Highlights Published on 2021-01-272022-10-30 Journal: mSphere [Category] COVID-19, [키워드] approaches benefit Canada Clinical studies Clinicians Diseases effective Epidemiology evaluated expert Focusing Generation Health Immunity immunization immunology implementation IMPROVE Infant Infection Infectious disease integration Maternal maternal immunization morbidity and mortality Neonatal novel pregnant women primer protection provide provided public health representing Research Sustainable Development Goals symposium United Nation vaccination Vaccine acceptance Vaccine development vaccine safety vaccines in pregnancy [DOI] 10.1128/mSphere.00862-20 PMC 바로가기 [Article Type] Meeting Highlights
Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional SurveysArticle Published on 2021-01-182022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acceptance adjusted alcohol change Compliance conducted COVID-19 COVID-19 vaccine cross-sectional survey decreasing education Effectiveness Epidemic First wave health behaviour Hesitancy higher risk Hong Kong less Local Occupation participant provided reason responses social distancing the vaccine threat vaccination Vaccine Vaccine acceptance Vaccine development Vaccine hesitancy vaccine safety was measured Wave working [DOI] 10.3390/vaccines9010062 PMC 바로가기 [Article Type] Article